SCHEMBL1014869

SCHEMBL1014869

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)Nc1cccc(Cc2ccoc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 4/20 0.53
MAPT P10636 5/20 0.41
ALDH1A1 P00352 4/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C19 P33261 2/20 0.41
GAA P10253 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP2C9 P11712 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
POLB P06746 3/20 0.40
KDM4E B2RXH2 2/20 0.40
MAPK10 P53779 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAPK1 P28482 1/20 0.39
TP53 P04637 2/20 0.39
THRB P10828 1/20 0.39
LMNA P02545 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015401 0.91 SERPINE1 (0.64) SERPINE1MAPTALDH1A1GAASMN1; SMN2
SCHEMBL1015206 0.86 KDM4E (0.47) SERPINE1MAPTALDH1A1CYP1A2CYP3A4
SCHEMBL1015662 0.85 SERPINE1 (0.64) SERPINE1MAPTALDH1A1CYP1A2CYP3A4
SCHEMBL1013909 0.80 SERPINE1 (0.57) SERPINE1MAPTALDH1A1CYP1A2CYP3A4
SCHEMBL1018800 0.80 GRIK1 (0.47) SERPINE1MAPTALDH1A1CYP1A2CYP3A4
SCHEMBL1015672 0.80 ALDH1A1 (0.58) MAPTALDH1A1GAAMEN1KMT2A
SCHEMBL1016588 0.79 SERPINE1 (0.51) SERPINE1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL1015802 0.79 SERPINE1 (0.84) SERPINE1MAPTALDH1A1CYP1A2CYP3A4
SCHEMBL1015514 0.78 SERPINE1 (0.44) SERPINE1MAPTALDH1A1CYP1A2CYP3A4
SCHEMBL1016295 0.78 LCLAT1 (0.49) SERPINE1MAPTALDH1A1CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 SERPINE1 1/4885MAPT 3139/4885ALDH1A1 888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.